EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on H. pylori Management (Hp‐ BrazilReg )

B S F Sanches iD, O P Nyssen, S R Chaves, J S Veloso, L S Silva, J R Marinho, H Okamoto, G C Couto, H P Breyer, C S Alencar, E Comelli, L S Sousa und 39 weitere

Helicobacter · 2025

DOI: 10.1111/hel.70077 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Helicobacter, 2025. Verfasst von B S F Sanches und 50 weiteren Autor:innen. Beteiligte Einrichtung: Universidade Federal de Minas Gerais, Belo Horizonte, Brazil. Hauptthemen laut MEDLINE: Helicobacter Infections, Anti-Bacterial Agents, Helicobacter pylori. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Núcleo Brasileiro para estudo do Helicobacter pylori e Microbiota.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The effectiveness of anti ‐ H. pylori treatment diminishes with therapy failure, making regional performance understanding crucial.

Objective

To evaluate the effectiveness of empirical therapy in second‐line and subsequent treatments in Brazil.

Methods

A multicenter, prospective, noninterventional registry assessed H. pylori management outcomes by Brazilian gastroenterologists (Hp‐BrazilRe, Hp‐ WorldReg 's partner). Data were registered at e‐ CRF AEG ‐ ReCap from March 2022 to October 2024 and analyzed via modified intention‐to‐treat ( mITT ) methodology. Data were subject to quality review.

Results

572 patients (mean age 52 years, 64% women) were included. The primary treatment indications were dyspepsia (64%) and gastroduodenal ulcer (9.2%). Among them, 67% underwent second‐line therapy, while 33% received third‐line or subsequent treatments. Proton‐pump inhibitors ( PPIs ) were administered at low (40%), standard (10%), and high doses (24%), with vonoprazan used in 26% of cases. The overall eradication rate for second‐line treatment was 74%, with the most common regimen being triple therapy ( PPI + amoxicillin + levofloxacin), achieving 73% eradication for 14 days and 57% for 10 days. Adding bismuth to the 14‐day regimen increased effectiveness to 100% ( p = 0.016). In third‐line therapy, a regimen of PPI ‐bismuth‐tetracycline‐metronidazole yielded an 87% cure rate. The fourth‐line dual therapy with amoxicillin‐vonoprazan achieved 100% eradication, while bismuth‐quadruple therapy showed similar results. Dual therapy with vonoprazan and amoxicillin was also effective in fifth‐line treatments, achieving 100% effectiveness. Mild adverse events occurred in 23% of patients, with nausea being the most common (14%), and compliance was 99%.

Conclusion

In Brazil, the overall effectiveness of second‐line therapy was suboptimal (< 90%); however, the combination of bismuth‐amoxicillin‐levofloxacin prescribed for 14 days reported successful cure rates. In the third‐line, the classical bismuth‐quadruple therapy with metronidazole‐tetracycline provided acceptable results (87%). Alternatively, dual therapy with vonoprazan and amoxicillin and rifabutin‐based bismuth‐quadruple therapy showed promising results in third‐ and fifth‐line rescue treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Helicobacter InfectionsAnti-Bacterial AgentsHelicobacter pyloriHumansFemaleMaleMiddle AgedBrazilProton Pump InhibitorsAdultRegistriesProspective StudiesAgedDrug Therapy, CombinationTreatment OutcomeAmoxicillinYoung AdultPyrrolesSulfonamides

Stichwörter der Autor:innen

Helicobacter pyloriempirical treatmentregistryretreatmenttreatment failure

Substanzen

Anti-Bacterial AgentsProton Pump Inhibitors1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamineAmoxicillinPyrrolesSulfonamides

Autor:innen und Institutionen

  • Universidade Federal de Minas Gerais, Belo Horizonte, Brazil.
  • Biocor Instituto, Belo Horizonte, Brazil.
  • Gastroenterology Unit, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), and Centro de Investigación Biomédica en Red de Enfermeda…
  • Rede Mater Dei de Saude, Belo Horizonte, Brazil.
  • Hospital Santa Helena, Brasilia, Brazil.
  • Hospital Adventista de Manaus, Manaus, Brazil.

ORCID-Profile: B S F Sanches, H S Souza, J P Gisbert

Förderung

  • Núcleo Brasileiro para estudo do Helicobacter pylori e Microbiota

Zitieren

APA

Sanches, B. S. F., Nyssen, O. P., Chaves, S. R., Veloso, J. S., Silva, L. S., Marinho, J. R., Okamoto, H., Couto, G. C., Breyer, H. P., Alencar, C. S., Comelli, E., Sousa, L. S., Horn, M., Massote, M. G., Loures, M. T. R., Vidal, M. P., Paula, R. V., Ribeiro, L. T., Galizzi, H. O., …, & Hp‐BrazilReg (2025). Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on H. pylori Management (Hp‐ BrazilReg ). Helicobacter. https://doi.org/10.1111/hel.70077

Vancouver

Sanches BSF, Nyssen OP, Chaves SR, Veloso JS, Silva LS, Marinho JR, et al. Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on H. pylori Management (Hp‐ BrazilReg ). Helicobacter. 2025. doi:10.1111/hel.70077

BibTeX
@article{Sanches2025,
  author = {Sanches, B S F and Nyssen, O P and Chaves, S R and Veloso, J S and Silva, L S and Marinho, J R and Okamoto, H and Couto, G C and Breyer, H P and Alencar, C S and Comelli, E and Sousa, L S and Horn, M and Massote, M G and Loures, M T R and Vidal, M P and Paula, R V and Ribeiro, L T and Galizzi, H O and Terra, D A A and Cançado, G G L and Burmann, B P and Caetano, J S and Pena, L F and Decanio, M A and Souza, H S and Kuniyoshi, A S O and Guedes, L R and Passos, M C F and Marinho, F P and Bombassaro, I Z and Domingues, A G and Barbosa, J G and Nogueira, I M and Ramos, A F P and Korman, D R and Souza, T B and Barbosa, M C and Chinzon, D and Silva, L L and Mantovani, A and Freitas, A H A and Poncinelli, C S and Francato, M A and Goncalves, J N and Parra, P and Cano-Català, A and Moreira, L and Gisbert, J P and Coelho, Luiz Gonzaga Vaz and Hp‐BrazilReg, Hp‐BrazilReg},
  title = {Empirical Rescue Eradication Therapy for Helicobacter pylori Infection in Second and Subsequent Treatment Lines: Experience From 500 Cases of the Brazilian Registry on H. pylori Management (Hp‐ BrazilReg )},
  journal = {Helicobacter},
  year = {2025},
  doi = {10.1111/hel.70077}
}
Kostenlos starten →